4//SEC Filing
ARRAY BIOPHARMA INC 4
Accession 0001104659-15-016809
CIK 0001100412operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:12 PM ET
Size
9.0 KB
Accession
0001104659-15-016809
Insider Transaction Report
Form 4
SNITMAN DAVID
DirectorCOO and VP, Business Devel.
Transactions
- Exercise/Conversion
Common Stock
2015-03-01$7.96/sh+11,453$91,166→ 11,453 total - Tax Payment
Common Stock
2015-03-01$7.96/sh−3,976$31,649→ 7,477 total - Exercise/Conversion
Restricted Stock Units
2015-03-01−11,453→ 11,453 totalExp: 2018-08-18→ Common Stock (11,453 underlying)
Footnotes (3)
- [F1]Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on August 18, 2014 as a result of the vesting of one half of such RSU's.
- [F2]Represents shares withheld to satisfy tax withholding obligations of the reporting person.
- [F3]RSU's were awarded to the reporting person for no additional cash consideration and represent a contingent right to receive one share of Array BioPharma Inc. common stock. RSU's representing 11,453 shares of common stock vested on March 1, 2015 and 11,453 shares remain unvested and subject to achievement of a second milestone relating to the return of rights to binimetinib to the issuer on or prior to the fourth anniversary of the grant date, in each case subject to continued service with the Company as of each vesting date.
Documents
Issuer
ARRAY BIOPHARMA INC
CIK 0001100412
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001100412
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:12 PM ET
- Size
- 9.0 KB